StonvexLoading…
StonvexStonvexStonvexCore line items from NEOG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $894.66M | $924.22M | $822.45M | $527.16M |
Operating Income | $-1.06B | $58.66M | $37.52M | $58.62M |
Net Income | $-1.09B | $-9.42M | $-22.87M | $48.31M |
EPS (Diluted) | $-5.03 | $-0.04 | $-0.12 | $0.45 |
Total Assets | $3.44B | $4.55B | $4.55B | $992.93M |
Total Liabilities | $1.37B | $1.40B | $1.42B | $105.56M |
Cash & Equivalents | $129.00M | $170.61M | $163.24M | $44.47M |
Free Cash Flow OCF − CapEx | $-46.35M | $-76.16M | $-24.73M | $43.61M |
Shares Outstanding | 216.61M | 217.04M | 216.25M | 107.80M |